Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care

Last updated: March 31, 2026
Sponsor: Accexible
Overall Status: Completed

Phase

N/A

Condition

Dementia

Mild Cognitive Impairment

Memory Loss

Treatment

Speech analysis

Clinical Study ID

NCT05380297
PS2020056
  • Ages 55-90
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration.

A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness.

Thus, the purpose of this study is to validate speech analysis AI models.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult patients 55+ years of age with suspected MCI or diagnosis of dementia and obtains a score greater than 20 on the MMSE.

  • Patients must have agreed to participate in the study and have voluntarily signed the informed consent.

  • (Healthy) Participants without a diagnosis neurological, or psychiatric disorders. Or taking medication that can affect cognitive abilities.

Exclusion Criteria

  • To have received a diagnosis of a significant psychiatric disorder or other cognitive impairment not due to neurodegeneration.

  • To have significant vision problems that would affect the ability to perceive visual stimuli.

  • To have significant hearing problems that would affect the ability to understand verbal cues.

Study Design

Total Participants: 273
Treatment Group(s): 1
Primary Treatment: Speech analysis
Phase:
Study Start date:
May 17, 2021
Estimated Completion Date:
April 18, 2024

Connect with a study center

  • País Vasco

    País Vasco, Basque Country
    Spain

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.